Clinical Trials Insight: 700019543

Trial Profile

Clinical Trials Insight: 700019543

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Vidofludimus (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 11 Jul 2008 Results have been reported at EULAR 2008.
    • 29 Nov 2007 Preliminary results reported in a 4SC media release.
    • 08 Oct 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top